Skip to main content
. 2019 Mar 5;2019:18-0157. doi: 10.1530/EDM-18-0157

Table 2.

Serial echocardiography at baseline and during somatostatin analogue therapy.

Duration of treatment (months) LVIDd, cm LVEF, %
−46 5.5 ‘Severely reduced systolic function’
0 7.0 20–25
6 7.2 28
13 7.3 20–25
21 6.9 28

LVIDd, left ventricular internal diameter in diastole; LVEF, left ventricular ejection fraction.